Literature DB >> 16683856

The nature of the discontinuation syndrome associated with antidepressant drugs.

Richard C Shelton1.   

Abstract

A common phenomenon accompanying treatment with nearly every major class of antidepressant is the emergence of the discontinuation syndrome in some patients. It is seen most frequently after the abrupt cessation of agents with shorter half-lives. The term withdrawal has been used in the past; however, the distinctions between discontinuation symptoms and drug withdrawal are clear. Thus, the use of proper terminology when discussing this phenomenon with patients will help to alleviate concerns and stop the spread of common misperceptions. In addition, awareness of the unique nature of discontinuation effects and a grasp of the typical time frame of their emergence can assist in distinguishing between discontinuation syndrome and relapse. As a result, it is vital that both patients and their relatives, especially caregivers, be provided with adequate education and a realistic and objective appraisal of expected outcomes upon initiation of antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16683856

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

Review 1.  Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Authors:  Branislav R Filipovic; Branka F Filipovic
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

2.  A case report of onset of tinnitus following discontinuation of antidepressant and a review of the literature.

Authors:  Jane Clewes
Journal:  Prim Care Companion CNS Disord       Date:  2012-02-16

Review 3.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

4.  Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review.

Authors:  Boadie W Dunlop; Paula G Davis
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

5.  Pharmacotherapy of mood disorders and treatment discontinuation.

Authors:  Malcolm Lader
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.

Authors:  Amy Yang; Jody D Ciolino; Emily Pinheiro; Laura J Rasmussen-Torvik; Dorothy K Y Sit; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2017-05       Impact factor: 4.384

Review 7.  A review of the management of antidepressant discontinuation symptoms.

Authors:  Emma Wilson; Malcolm Lader
Journal:  Ther Adv Psychopharmacol       Date:  2015-12

8.  A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD).

Authors:  Antonina A Mikocka-Walus; Andrea L Gordon; Benjamin J Stewart; Jane M Andrews
Journal:  BMC Gastroenterol       Date:  2012-07-20       Impact factor: 3.067

9.  Prescribing ANtiDepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care.

Authors:  Esther Muskens; Rhona Eveleigh; Peter Lucassen; Chris van Weel; Jan Spijker; Peter Verhaak; Anne Speckens; Richard Oude Voshaar
Journal:  BMC Fam Pract       Date:  2013-01-08       Impact factor: 2.497

10.  Duloxetine in the management of diabetic peripheral neuropathic pain.

Authors:  Michelle J Ormseth; Beth A Scholz; Chad S Boomershine
Journal:  Patient Prefer Adherence       Date:  2011-07-19       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.